The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.
The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and who are enrolled in Aware Recovery Care's In-Home Addiction Treatment program where Care Teams will monitor cloud-based breathalyzer results. Soberlink's cloud-based breathalyzer system will provide data to Care Team if the Client has relapsed or is not compliant with testing through the Soberlink System. Clients will use Soberlink for 180 days within context of routine alcohol use disorder treatment at Aware Recovery Care.
Study Type
OBSERVATIONAL
Enrollment
30
Soberlink delivers real-time blood alcohol results to people who support individuals in recovery from alcohol use disorder. In-Home Addiction Treatment program Care Team monitors and responds to results as part of care to improve treatment outcomes.
Aware Recovery Care
North Haven, Connecticut, United States
Aware Recovery Care
Bedford, New Hampshire, United States
Rate of Retention in Treatment
Participation in In-Home Addiction Treatment program using length of stay reports.
Time frame: 180 days duration of subject participation
Brief Addiction Monitor questionnaire
Measure change in client report of symptoms related to alcohol use disorder
Time frame: Conducted monthly throughout 180 days duration of subject participation
Positive Outcomes Measures Survey
Measures changes in quality of life using client self-report inquiring about employment, connection to care team, community engagement using yes/no answer key
Time frame: Completed at week 3 or 4 and Week 20 during 180 days duration of subject participation
Client Survey Related to use of Soberlink
Measures self-report of quality of life and experience with device using 5-point Likert scale (minimum Strongly Disagree, maximum Strongly Agree)
Time frame: Completed at end of 180 days duration of subject participation
Relapse Rates
Occurrence of alcohol use
Time frame: Measured throughout 180 days duration of subject participation
Compliance with Testing
Occurrence of Missed Tests
Time frame: Measured throughout 180 days duration of subject participation
Hospitalization
Occurrence of Emergency Room and Inpatient hospital admissions
Time frame: Measured throughout 180 days duration of subject participation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Detox and Residential Admissions
Occurrence of residential treatment and detox admissions
Time frame: Measured throughout 180 days duration of subject participation